Suscribirse

Normocapnia improves cerebral oxygen delivery during conventional oxygen therapy in carbon monoxide–exposed research subjects - 01/09/11

Doi : 10.1067/mem.2002.129723 
Joshua Rucker, MD, Janet Tesler, MSc, Ludwik Fedorko, MD, PhD, Akinori Takeuchi, MD, PhD, Luciana Mascia, MD, Alex Vesely, MSc, Sasha Kobrossi, BSc, Arthur S. Slutsky, MD, George Volgyesi, PEng, Steve Iscoe, PhD, Joseph A. Fisher, MD
Department of Anesthesia, University Health Network, University of Toronto, Toronto, Ontario, Canada (Rucker, Tesler, Fedorko, Mascia, Vesely, Kobrossi, Volgyesi, Fisher); the Department of Anesthesia and Resuscitology, Nagoya City University Medical School, Nagoya, Japan (Takeuchi); the Department of Critical Care Medicine and Department of Medicine, St. Michael's Hospital, Toronto, Ontario, Canada (Slutsky); and the Department of Physiology, Queens University, Kingston, Ontario, Canada (Iscoe) 

Abstract

Study objective: We determine whether maintaining normocapnia during hyperoxic treatment of carbon monoxide–exposed research subjects improves cerebral oxygen delivery. Methods: This experiment used a randomized, single-blinded, crossover design. We exposed 14 human research subjects to carbon monoxide until their carboxyhemoglobin levels reached 10% to 12%. We then treated each research subject with 60 minutes of hyperoxia with or without normocapnia. Research subjects returned after at least 24 hours, were reexposed to carbon monoxide, and were given the alternate treatment. Relative changes in cerebral oxygen delivery were calculated as the product of blood oxygen content and middle cerebral artery velocity (an index of cerebral blood flow) as measured by transcranial Doppler ultrasonography. Results: Maintaining normocapnia during hyperoxic treatment resulted in significantly higher cerebral oxygen delivery compared with standard oxygen treatment (P <.05; 95% confidence interval at 60 minutes 2.8% to 16.7%) as a result of the prevention of hypocapnia-induced cerebral vasoconstriction and more rapid elimination of carbon monoxide due to increased minute ventilation. Conclusion: If severely poisoned patients respond like our research subjects, maintaining normocapnia during initial hyperoxic treatment of carbon monoxide poisoning may lead to increased oxygen delivery to the brain. Determining the effect of such a change in conventional treatment on outcome requires clinical studies. [Ann Emerg Med. 2002;40:611-618.]

El texto completo de este artículo está disponible en PDF.

Esquema


* Supported in part by the Department of Anesthesia of The University Health Network, University of Toronto, and the Tobi and Ted Bekhor Foundation.
** A number of methods have been described for maintaining normocapnia without rebreathing and are thus suitable for application to carbon monoxide poisoning. The authors have developed one such method and applied for patent protection under the guidelines of the University of Toronto. After the completion of the studies described in the paper, the method was licensed to a commercial concern.
* Address for reprints: Joseph A. Fisher, MD, FRCP(C), Department of Anesthesia, Toronto General Hospital, 200 Elizabeth Street, 3 Eaton N, Toronto, Ontario, Canada M5G 2C4; 416-340-4800 ext. 3071,fax 416-340-3698; E-mail joe.fisher@utoronto.ca


© 2002  American College of Emergency Physicians. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 40 - N° 6

P. 611-618 - décembre 2002 Regresar al número
Artículo precedente Artículo precedente
  • Electrocardiographic changes associated with ?-blocker toxicity
  • Jeffrey N. Love, Brett Enlow, John M. Howell, Wendy Klein-Schwartz, Toby L. Litovitz
| Artículo siguiente Artículo siguiente
  • Crotalidae polyvalent immune fab (ovine) antivenom is efficacious for envenomations by southern pacific rattlesnakes (Crotalus helleri )
  • Sean P. Bush, Steven M. Green, James A. Moynihan, William K. Hayes, Michael D. Cardwell

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.